healthcare

production

Molina Healthcare Inc

Molina Healthcare upgraded by StockNews.com to strong-buy.

It also produces better care outcomes at a lower cost than traditional Medicare.

Cano Health Inc - Ordinary Shares - Class A

insider

Unfortunately, CANO insiders have significant influence on the future of the company, I.e.

The problem with CANO is that insiders have too many shares (-32%} and it’s difficult for any activists to force them to change direction.

What mesmerizes me is the absolute brutal execution of corporate and personal governances by insiders as they have lost hundreds of millions of dollars.

The layoffs, lack of communication, and lack of insider trades says a lot… also the clear manipulation of the stock by who knows who…

We shall see how things unfold soon.

post

$CANO If I weren&#39;t so tired of all the shenanigans, I&#39;d post a rocket gif.

they post negative BS every day, and their predictions are always wrong.

$CANO not looking good, after ER Marleen still MIA an No comments.

Because someone needs to call the poster out for the fabrications and BS that the poster posts.

Look like something a Paid shill would post.

Your posts make me think of a toddler throwing a tantrum.

but the comments here are mostly stupid and completely useless.

pump-and-dump

$CANO is increadible how ppl still pump this for a BO when nobody wants this company and it keeps going down to sub-pennies soon, you can tell they did not do their homework and they dont understand financials.

$1s .. so stop TEMPTING people with any bs pump .. Buy at dips only !! GL

$CANO Enough with this Humana bs you twats and give us a God damn BO or an fen pump !😤😡🤬

?,  for ppl that if you do not agreed with their pump they start bashing and crying.

$CANO not good not good at all we&#39;ve dumped been side ways and now back to dump

Pumps at open n dumps rest of the day. Sickening

$CANO This was Pump &amp; Dump and Now it&#39;s developed into a Unmitigated Disaster.

reason

it has to lead you to believe that someone is manipulating the price for some reason. ..

$CANO down yet again for absolutely no reason

This reflects negatively on the SP for obvious reasons.

not looking good, theres a reason is a $1 stock and OSH is @ $35.

$CANO this dropped for no reason just manipulation.

I also see NO reason to have an expectation for Monday.

shareprice

Management better step up for some SP stability.

Company not paying any attention to how bad the SP is.

$CANO Like I said earlier healthcare sector is up today, it&#39;s a recession proof sector.

$CANO Today is 1/18/23 and Dr. Marlow may have the biggest smile of any Healthcare CEO of all time!

Add to that CANO has better numbers, more centers(many with the capacity to double in membership).

$FRC same happening with $CANO market cap 500M , 3 billion revenues 2023

Just buy and hold

Remember always buy the blood!

$CANO 

Buy buy buy and take it to the bank

$CANO 

Buy buy buy duck the shares out of the shorts mouth!!

market

CANO is way to cheap and has a clear path to profitability in a massive growth market with M&amp;A activity on going this year.

$CANO market is rallying after CPI and banks under control

$CANO @kriswing normal market movement 😂

what a great business, sector, and leadership to have your money tied to in a market such as this. $CANO

Looks like Mr Market will be re-rating CANO upwards in a big way!!

$CANO market will still rally no matter what Pow Wow says.

$CANO The biggest POS in the market continues to show it&#39;s colors again.. thanks management! !

The Fundamentals are excellent, the market segment is HOT.

$CANO 
Holding pretty good for a penny stock while the market is bleeding red!

$CANO 🚀🔥🔥 has no one seen this wow I&#39;m buying more 🔥🔥🚀🚀🚀🚀

Amyris Inc

partner

He has a history of being a bad partner and they also may not want to get into bed with a company with a balance sheet like this.

$IBRX $AMRS Bad news from our partner ImmunityBio.

Partner with more celebs and bring more unprofitable derivative products to market!

world

It&#39;s fake because in the real world it doesn&#39;t exist!!!

fund

&quot;Amyris: In Danger Of Running Out Of Funds After Delay To Key Strategic Transaction&quot; 
 
Suspicious is that negative reports about AMRS at SA are always freely accessible and you do not need a subscription.

$VKTX i moved all my funds from here to $AMRS … what a failure I am ..! !

But many, it has been brutal over the past year and no sign of it stopping: 
 
Cathie Wood’s popular ARK Innovation ETF to a new 30-month trading low on Tuesday after the innovation-based fund ended in negative territory for the third straight session.

trading

$AMRS trading 101 .. always the same nonsense dip, keeping it in check. This time was bit boring slow, stealing shares :)

• $AMRS – fell 23.5% to $1.98 in pre-market trading after the company reported worse-than-expected Q3 results 
• $CARG - shares fell 23% to $10.60 in pre-market trading after the company reported worse-than-expected Q3 results.

In the real world of trade, selling non existing goods is called fraud!!!

afterhours

They have completed initial due diligence and are impressed with what we have built at Barra Bonita and the quality of our equipment and overall capacity.

The big surprise of the CC: 
- We are in active discussions regarding a manufacturing joint venture.

Something that would create great market excitement… 

However “The factory move could become a game changer!

This is the ingredient that Amyris produces the most.

- Scale-up and industrial production at BB at low cost.

The fact that Amyris develops ingredients and molecules from the R&amp;D stage all the way up to production at an incredible scale and that it is able to do so in a sustainable way - that is something I was eager to be a part of and help grow.&quot;

Plenty of people see value in $AMRS, as their technology is world class and their production capabilities in synbio are without peer.

Bonus to the almost half billion revenue: A big chance to positive news on scaling up production in Brazil.

It also appears to lend itself more readily to the production of a wide range of proteins.

Their technology in a very promising sector appears leading edge, and their production capabilities are unmatched anywhere.

product

Terasana is probably a very good product,

This brand is growing extremely naturally and when mom’s approve of a product they tend to spread like wildfire and we’re seeing that.

Just disaster after disaster, it&#39;s unbelievable when the products are just so incredible.

They do have more than enough for now .. and more R&amp;D is coming, plus the steady product sales revs.

This shelf has been restocked which means 4U by Tia is selling pretty good (better than any other consumer product Amyris ever developed) and the company did not run out of cash.

I should add that the product seems fine, fast and free shipping, well packaged, fair price… why does this not appear to be selling?

Buy the product,  try it and spread the word.

$AMRS These were full of our curlyhair product, amazing.

Also news on their latest line of products sound optimistic. BULLISH

sale

$AMRS Combo of sales momentum, improving margins (Barra Bonita), new molecule deal with potential for more, and other planned initiatives, means there won&#39;t be dilution.

$AMRS Regardless of whether the molecule licensing sale goes through or not, the stock will go up meaningfully.

short sale volume can be seen as a bullish indicator.

67% of shares sold were short sales and still bulls won this battle.

but revenue growth continues to be solid and they just had their record black Friday sales which will be reflected on next ER.

Yearly ST licence deals with increasing sales value combined with own increasing brand revenue and increase scaling producing for own brands and licence partners with an efficient and top notch production facility!!!

revenue

They are doing an excellent job expanding the market for our Reb M. This ingredient is expected to be in the top 3 ingredients for revenue by 2023 and is growing at a faster pace than we had planned.

Exactly what I expected, revenue was a bit higher than I anticipated 😅

All this should result in more revenue, royalties and profits 🚀 🚀 🚀.

$AMRS
This means that both amyris hemisqualane and amyris squalane will stay owned by Amyris and both can be commercialized individually or combined in a strategic transaction or more for more revenue streams. Success!

$AMRS 
About 4% of the hair care market share from the people with curly hair in USA will make the $140M revenue to Amyris from 4U by Tia Mowry. Success!

20M units sold in 2023 and $140M revenue from 4U by Tia Mowry is very possible. Success!

Top Stocks matching your search for "healthcare manufacturing"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

MOH

Molina Healthcare Inc

-13.70%

$307.17 - $265.09

Mar, 16, 2023

CANO

Cano Health Inc - Ordinary Shares - Class A

-33.72%

$1.72 - $1.14

Mar, 10, 2023

Jan, 18, 2023

AMRS

Amyris Inc

-15.82%

$1.58 - $1.33

MOH

Molina Healthcare Inc

-13.70%

$307.17 - $265.09

Mar, 16, 2023

CANO

Cano Health Inc - Ordinary Shares - Class A

-33.72%

$1.72 - $1.14

Mar, 10, 2023

Jan, 18, 2023

AMRS

Amyris Inc

-15.82%

$1.58 - $1.33